Results 211 to 220 of about 107,669 (285)

The potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study

, 2023
Clark RA, Portnoy A, Weerasuriya CK, Sumner T, Bakker R, Harris RC, Rade K, Mattoo SK, Tumu D, Menzies NA, White RG.   +10 more
europepmc   +1 more source

Estimating the annual risk of infection with Mycobacterium tuberculosis among adolescents in Western Kenya in preparation for TB vaccine trials [PDF]

, 2019
Videlis Nduba, Anna H. van’t Hoog, Annefleur de Bruijn, Ellen M.H. Mitchell, Kayla Laserson, Martien W. Borgdorff   +5 more
openalex   +1 more source

New Advances in the Development and Design of <i>Mycobacterium tuberculosis</i> Vaccines: Construction and Validation of Multi-Epitope Vaccines for Tuberculosis Prevention. [PDF]

Biology (Basel)
Barazani O, Erdos T, Chowdhury R, Kaur G, Venketaraman V.   +4 more
europepmc   +1 more source

Immunology of CBPP: current knowledge [PDF]

, 2014
Totté, Philippe
core  

Model-based impact evaluation of new tuberculosis vaccines in aging populations under different modeling scenarios: the case of China. [PDF]

Front Public Health
Tovar M, Sanz J, Moreno Y.
europepmc   +1 more source

Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case.

Vaccine, 2022
Kochhar S, Barreira D, Beattie P, Cavaleri M, Cravioto A, Frick MW, Ginsberg AM, Hudson I, Kaslow DC, Kurtz S, Lienhardt C, Madhi SA, Morgan C, Momeni Y, Patel D, Rees H, Rogalski-Salter T, Schmidt A, Semete-Makokotlela B, Voss G, White RG, Zignol M, Giersing B.   +22 more
europepmc   +1 more source

Perspectives for Developing New Tuberculosis Vaccines Derived from the Pathogenesis of Tuberculosis: I. Basic Principles, II. Preclinical Testing, and III. Clinical Testing [PDF]

, 2013
Arthur M. Dannenberg, Bappaditya Dey
openalex   +1 more source

Lung IL-17A-Producing CD4⁺ T Cells Correlate with Protection after Intrapulmonary Vaccination with Differentially Adjuvanted Tuberculosis Vaccines. [PDF]

Vaccines (Basel)
Stewart EL, Counoupas C, Quan DH, Wang T, Petrovsky N, Britton WJ, Triccas JA.   +6 more
europepmc   +1 more source

Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccines. [PDF]

Commun Biol, 2020
Rozot V, Nemes E, Geldenhuys H, Musvosvi M, Toefy A, Rantangee F, Makhethe L, Erasmus M, Bilek N, Mabwe S, Finak G, Fulp W, Ginsberg AM, Hokey DA, Shey M, Gurunathan S, DiazGranados C, Bekker LG, Hatherill M, Scriba TJ, C-040-404 Study Team.   +20 more
europepmc   +1 more source

A Novel Therapeutic and Prophylactic Vaccine (HVJ-Envelope / Hsp65 DNA + IL-12 DNA) against Tuberculosis Using the Cynomolgus Monkey Model

, 2010
Masaji Okada, Yoko Kita, Takeshi Nakajima, Noriko Kanamaru, Satomi Hashimoto, Yasuko Nishida, Hisayuki Nakatani, Ken‐ichi Takao, Chie Kishigami, Shiho Nishimatsu, Yoshihiro Sekine, Yoshikazu Inoue, T Nagasawa, Y Kaneda, Shigeto Yoshida, M Matsumoto, Saunderson Paul, Esterlina V. Tan, Eduardo Canteiro Cruz, David N. McMurray, Mitsunori Sakatani   +20 more
openalex   +1 more source